{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:23:11Z","timestamp":1793193791349,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":2288,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Health & Medical Research Council of Australia"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1111\/jth.13293","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T09:36:47Z","timestamp":1455529007000},"page":"1642-1654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Inhibition of protease\u2010activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood"],"prefix":"10.1016","volume":"14","author":[{"given":"S.L.","family":"French","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.S.","family":"Nesbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.K.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.E.","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13293_bb0010","first-page":"e29","article-title":"Heart disease and stroke statistics \u2013 2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1111\/jth.13293_bb0015","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(14)61652-4","article-title":"On World Thrombosis Day","volume":"384","author":"Rosendaal","year":"2014","journal-title":"Lancet"},{"key":"10.1111\/jth.13293_bb0020","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","article-title":"Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation","volume":"64","author":"Vu","year":"1991","journal-title":"Cell"},{"key":"10.1111\/jth.13293_bb0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI115592","article-title":"Characterization of a functional thrombin receptor. Issues and opportunities","volume":"89","author":"Coughlin","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13293_bb0030","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/353674a0","article-title":"Domains specifying thrombin\u2013receptor interaction","volume":"353","author":"Vu","year":"1991","journal-title":"Nature"},{"key":"10.1111\/jth.13293_bb0035","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI115721","article-title":"Cloned platelet thrombin receptor is necessary for thrombin\u2010induced platelet activation","volume":"89","author":"Hung","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13293_bb0040","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/386502a0","article-title":"Protease\u2010activated receptor 3 is a second thrombin receptor in humans","volume":"386","author":"Ishihara","year":"1997","journal-title":"Nature"},{"key":"10.1111\/jth.13293_bb0045","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/29325","article-title":"A dual thrombin receptor system for platelet activation","volume":"394","author":"Kahn","year":"1998","journal-title":"Nature"},{"key":"10.1111\/jth.13293_bb0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease\u2010activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"10.1111\/jth.13293_bb0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/35092573","article-title":"Role of thrombin signalling in platelets in haemostasis and thrombosis","volume":"413","author":"Sambrano","year":"2001","journal-title":"Nature"},{"key":"10.1111\/jth.13293_bb0060","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1182\/blood-2002-05-1470","article-title":"Protection against thrombosis in mice lacking PAR3","volume":"100","author":"Weiss","year":"2002","journal-title":"Blood"},{"key":"10.1111\/jth.13293_bb0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/blood-2003-08-2707","article-title":"Combined deficiency of protease\u2010activated receptor\u20104 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiency","volume":"103","author":"Camerer","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.13293_bb0070","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1538-7836.2004.00783.x","article-title":"Impaired hemostasis and protection against thrombosis in protease\u2010activated receptor 4\u2010deficient mice is due to lack of thrombin signaling in platelets","volume":"2","author":"Hamilton","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1073\/pnas.0610188104","article-title":"Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis","volume":"104","author":"Vandendries","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13293_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.blre.2008.06.002","article-title":"Protease\u2010activated receptors as targets for antiplatelet therapy","volume":"23","author":"Hamilton","year":"2009","journal-title":"Blood Rev"},{"key":"10.1111\/jth.13293_bb0085","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/eurheartj\/ehq320","article-title":"Double\u2010blind, placebo\u2010controlled Phase II studies of the protease\u2010activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high\u2010risk coronary artery disease","volume":"31","author":"Goto","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.13293_bb0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1109719","article-title":"Thrombin\u2010receptor antagonist vorapaxar in acute coronary syndromes","volume":"366","author":"Tricoci","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1111\/jth.13293_bb0095","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1111\/jth.13293_bb0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.blre.2014.10.006","article-title":"Approval of the first protease\u2010activated receptor antagonist: rationale, development, significance, and considerations of a novel anti\u2010platelet agent","volume":"29","author":"French","year":"2015","journal-title":"Blood Rev"},{"key":"10.1111\/jth.13293_bb0105","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2007-09-113837","article-title":"Angiogenesis is regulated by a novel mechanism: pro\u2010 and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released","volume":"111","author":"Italiano","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.13293_bb0110","doi-asserted-by":"crossref","first-page":"26665","DOI":"10.1074\/jbc.M602174200","article-title":"PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation","volume":"281","author":"Holinstat","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13293_bb0115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1124\/mol.112.083477","article-title":"Protease\u2010activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets","volume":"83","author":"Duvernay","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1111\/jth.13293_bb0120","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1055\/s-0037-1613071","article-title":"Role of the PAR4 thrombin receptor in stabilizing platelet\u2013platelet aggregates as revealed by a patient with Hermansky\u2013Pudlak syndrome","volume":"87","author":"Covic","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1160\/TH06-07-0397","article-title":"Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development","volume":"97","author":"Vretenbrant","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1476-5381.2010.00921.x","article-title":"The roles and mechanisms of PAR4 and P2Y12\/phosphatidylinositol 3\u2010kinase pathway in maintaining thrombin\u2010induced platelet aggregation","volume":"161","author":"Wu","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.13293_bb0135","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1021\/bi9927078","article-title":"Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets","volume":"39","author":"Covic","year":"2000","journal-title":"Biochemistry"},{"key":"10.1111\/jth.13293_bb0140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/BJ20101360","article-title":"Protease\u2010activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets","volume":"436","author":"Falker","year":"2011","journal-title":"Biochem J"},{"key":"10.1111\/jth.13293_bb0145","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1124\/mol.106.033365","article-title":"PAR1, but not PAR4, activates human platelets through a Gi\/o\/phosphoinositide\u20103 kinase signaling axis","volume":"71","author":"Voss","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1111\/jth.13293_bb0150","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/bj20030954","article-title":"Protease\u2010activated receptor\u20104 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage","volume":"376","author":"Jacques","year":"2003","journal-title":"Biochem J"},{"key":"10.1111\/jth.13293_bb0155","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1182\/blood-2012-07-445080","article-title":"Platelet secretion is kinetically heterogeneous in an agonist\u2010responsive manner","volume":"120","author":"Jonnalagadda","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13293_bb0160","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.1021\/bi00033a017","article-title":"Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets","volume":"34","author":"Williamson","year":"1995","journal-title":"Biochemistry"},{"key":"10.1111\/jth.13293_bb0165","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1021\/bi00036a039","article-title":"Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+\u2010ATPase inhibitors","volume":"34","author":"Dachary\u2010Prigent","year":"1995","journal-title":"Biochemistry"},{"key":"10.1111\/jth.13293_bb0170","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1111\/j.1538-7836.2007.02769.x","article-title":"Protease\u2010activated receptor\u2010induced Akt activation \u2013 regulation and possible function","volume":"5","author":"Resendiz","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0175","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/sj.bjp.0703437","article-title":"YD\u20103, a novel inhibitor of protease\u2010induced platelet activation","volume":"130","author":"Wu","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.13293_bb0180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1139\/y01-013","article-title":"Proteinase\u2010activated receptor 4 (PAR4): activation and inhibition of rat platelet aggregation by PAR4\u2010derived peptides","volume":"79","author":"Hollenberg","year":"2001","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1111\/jth.13293_bb0185","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.105.587758","article-title":"Blocking the protease\u2010activated receptor 1\u20134 heterodimer in platelet\u2010mediated thrombosis","volume":"113","author":"Leger","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/jth.13293_bb0190","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1073\/pnas.022460899","article-title":"Activation and inhibition of G protein\u2010coupled receptors by cell\u2010penetrating membrane\u2010tethered peptides","volume":"99","author":"Covic","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13293_bb0195","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nm760","article-title":"Pepducin\u2010based intervention of thrombin\u2010receptor signaling and systemic platelet activation","volume":"8","author":"Covic","year":"2002","journal-title":"Nat Med"},{"key":"10.1111\/jth.13293_bb0200","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/nm1203-1447a","article-title":"Inhibition of platelet thromboxane receptor function by a thrombin receptor\u2010targeted pepducin","volume":"9","author":"Stampfuss","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/jth.13293_bb0205","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjp.0705946","article-title":"Proteinase\u2010activated receptor\u20104: evaluation of tethered ligand\u2010derived peptides as probes for receptor function and as inflammatory agonists in vivo","volume":"143","author":"Hollenberg","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.13293_bb0210","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1055\/s-0037-1613128","article-title":"Selective inhibition of protease\u2010activated receptor 4\u2010dependent platelet activation by YD\u20103","volume":"87","author":"Wu","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0215","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI6042","article-title":"Protease\u2010activated receptors 1 and 4 mediate activation of human platelets by thrombin","volume":"103","author":"Kahn","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13293_bb0220","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1538-7836.2007.02590.x","article-title":"Controlled shedding of platelet glycoprotein (GP)VI and GPIb\u2013IX\u2013V by ADAM family metalloproteinases","volume":"5","author":"Gardiner","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0225","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.6648524","article-title":"Monoclonal antibodies to a synthetic fibrin\u2010like peptide bind to human fibrin but not fibrinogen","volume":"222","author":"Hui","year":"1983","journal-title":"Science"},{"key":"10.1111\/jth.13293_bb0230","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nbt.1995","article-title":"A zymogen\u2010like factor Xa variant corrects the coagulation defect in hemophilia","volume":"29","author":"Ivanciu","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1111\/jth.13293_bb0235","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1111\/j.1538-7836.2012.04928.x","article-title":"Platelet\u2010targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse","volume":"10","author":"Welsh","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0240","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1038\/ncomms7535","article-title":"The class II PI 3\u2010kinase, PI3KC2alpha, links platelet internal membrane structure to shear\u2010dependent adhesive function","volume":"6","author":"Mountford","year":"2015","journal-title":"Nat Commun"},{"key":"10.1111\/jth.13293_bb0245","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1160\/TH12-06-0389","article-title":"The PAR1 antagonist, SCH79797, alters platelet morphology and function independently of PARs","volume":"109","author":"Lee","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-61779-307-3_6","article-title":"A live cell micro\u2010imaging technique to examine platelet calcium signaling dynamics under blood flow","volume":"788","author":"Nesbitt","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1111\/jth.13293_bb0255","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3109\/09537104.2014.902924","article-title":"PAR1 antagonists inhibit thrombin\u2010induced platelet activation whilst leaving the PAR4\u2010mediated response intact","volume":"26","author":"Judge","year":"2015","journal-title":"Platelets"},{"key":"10.1111\/jth.13293_bb0260","doi-asserted-by":"crossref","first-page":"25216","DOI":"10.1074\/jbc.M004589200","article-title":"Protease\u2010activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin","volume":"275","author":"Shapiro","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13293_bb0265","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2003-04-1130","article-title":"Protease\u2010activated receptors 1 and 4 mediate thrombin signaling in endothelial cells","volume":"102","author":"Kataoka","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.13293_bb0270","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1160\/TH13-12-1013","article-title":"Thrombin\u2010induced platelet activation via PAR4: pivotal role for exosite II","volume":"112","author":"Boknas","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0275","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2014-09-599910","article-title":"Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar","volume":"125","author":"Aisiku","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13293_bb0280","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/jth.12619","article-title":"Targeting the anionic region of human protease activated receptor 4 (PAR4) inhibits platelet aggregation and thrombosis without interfering with hemostasis","volume":"12","author":"Mumaw","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0285","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1073\/pnas.96.20.11189","article-title":"Protease\u2010activated receptor 1 is the primary mediator of thrombin\u2010stimulated platelet procoagulant activity","volume":"96","author":"Andersen","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.13293_bb0290","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.ATV.0000167526.31611.f6","article-title":"Synergistic effect of thrombin on collagen\u2010induced platelet procoagulant activity is mediated through protease\u2010activated receptor\u20101","volume":"25","author":"Keuren","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13293_bb0295","doi-asserted-by":"crossref","first-page":"19728","DOI":"10.1074\/jbc.M909960199","article-title":"Structure\u2013function analysis of protease\u2010activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function","volume":"275","author":"Faruqi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13293_bb0300","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/09537101003660564","article-title":"Annexin V binding to platelets is agonist, time and temperature dependent","volume":"21","author":"Ramstrom","year":"2010","journal-title":"Platelets"},{"key":"10.1111\/jth.13293_bb0305","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1111\/jth.13293_bb0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.blre.2012.06.001","article-title":"Thrombin generation: what have we learned?","volume":"26","author":"Al Dieri","year":"2012","journal-title":"Blood Rev"},{"key":"10.1111\/jth.13293_bb0315","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1160\/TH11-06-0418","article-title":"The contribution of thrombin\u2010induced platelet activation to thrombus growth is diminished under pathological blood shear conditions","volume":"107","author":"Lee","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0320","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1160\/TH10-05-0305","article-title":"Combined blockade of thrombin anion binding exosite\u20101 and PAR4 produces synergistic antiplatelet effect in human platelets","volume":"105","author":"Wu","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13293_bb0325","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0002-9343(79)90392-9","article-title":"Isolated deficiency of platelet procoagulant activity","volume":"67","author":"Weiss","year":"1979","journal-title":"Am J Med"},{"key":"10.1111\/jth.13293_bb0330","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1111\/j.1476-5381.2012.01944.x","article-title":"Safety and efficacy of targeting platelet proteinase\u2010activated receptors in combination with existing anti\u2010platelet drugs as antithrombotics in mice","volume":"166","author":"Lee","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.13293_bb0335","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/jcbfm.2009.283","article-title":"Deficiency of PAR4 attenuates cerebral ischemia\/reperfusion injury in mice","volume":"30","author":"Mao","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1111\/jth.13293_bb0340","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2014-04-572479","article-title":"Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race","volume":"124","author":"Edelstein","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13293_bb0345","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/nm.3385","article-title":"Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR\u2010376c","volume":"19","author":"Edelstein","year":"2013","journal-title":"Nat Med"},{"key":"10.1111\/jth.13293_bb0350","first-page":"1","article-title":"PAR1 antagonists inhibit thrombin\u2010induced platelet activation whilst leaving the PAR4\u2010mediated response intact","volume":"26","author":"Judge","year":"2014","journal-title":"Platelets"},{"key":"10.1111\/jth.13293_bb0355","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/BJ20101360","article-title":"Protease\u2010activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets","volume":"436","author":"Knut","year":"2011","journal-title":"Biochem J"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13293","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13293","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622035231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622035231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13293\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:14:33Z","timestamp":1761534873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622035231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1538783622035231"],"URL":"https:\/\/doi.org\/10.1111\/jth.13293","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of protease\u2010activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}